植入前遗传学诊断后妊娠的产科与新生儿结局:队列研究及Meta分析
本研究比较了新鲜胚胎移植后植入前遗传学诊断(PGD)妊娠(n=89)与匹配的卵胞浆内单精子注射(ICSI)妊娠(n=166)的单胎及双胎临床妊娠结局,并进行了文献Meta分析。队列研究中67例PGD和118例ICSI妊娠的围产期结局相当;Meta分析显示除ICSI双胎妊娠低出生体重(<2500 g)率较高(RR 0.86,95% CI 0.74至1.0)外,其余结局相似。结论认为PGD与ICSI妊娠相比未发现不良新生儿或产科结局风险增加。
要点
- PGD与ICSI妊娠的围产期结局在队列研究中相当。
- Meta分析中ICSI双胎妊娠低出生体重率较高(RR 0.86,95% CI 0.74至1.0)。
- 平均出生体重、胎龄、早产(<37周)及畸形率均相当。
核心结论
- 本队列研究及后续Meta分析未发现PGD妊娠与ICSI妊娠相比增加不良新生儿或产科结局风险。
- 因此,用于PGD的卵裂球活检似乎不增加不良围产期结局风险。
研究设计与样本
- 单大学附属中心开展的队列研究,比较新鲜胚胎移植后PGD妊娠(n=89)与匹配的ICSI妊娠(n=166)的单胎及双胎临床妊娠结局。
- 因可用数据稀少,另进行了比较PGD与ICSI妊娠新生儿结局的文献Meta分析。
- 回顾性队列中,67例PGD和118例ICSI妊娠有产科和新生儿结局数据。
主要发现
- 队列研究中PGD与ICSI妊娠的围产期结局相当。
- Meta分析显示除ICSI双胎妊娠低出生体重(<2500 g)率较高(RR 0.86,95% CI 0.74至1.0)外,其余结局相似。
- 平均出生体重、出生时胎龄、早产(<37周)及畸形率均相当。
关键数值与推荐
- ICSI双胎妊娠低出生体重(<2500 g)率较高(RR 0.86,95% CI 0.74至1.0)。
- 平均出生体重、出生时胎龄、早产(<37周)及畸形率均相当。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Preimplantation genetic diagnosis (PGD) may pose risks to pregnancy outcome owing to the invasiveness of the biopsy procedure. This study compares outcome of singleton and twin clinical pregnancies conceived after fresh embryo transfers of PGD (n = 89) and matched intracytoplasmic sperm injection (ICSI) pregnancies (n = 166). The study was carried out in a single university affiliated centre. Because of the paucity of available data, a literature-based meta-analysis of studies comparing neonatal outcome of PGD and ICSI pregnancies was also conducted. In the retrospective cohort study, obstetric and neonatal outcome were available in 67 PGD and 118 ICSI pregnancies. Perinatal outcomes were comparable between PGD and ICSI pregnancies. Meta-analysis revealed similar outcomes, except for higher rate of low birth weight (<2500 g) neonates in ICSI twin pregnancies (RR 0.86, 95% CI 0.74 to 1.0). Mean birth weight, gestational age at birth, pre-term deliveries (<37 weeks) and malformations were all comparable. In this cohort study and subsequent meta-analysis, no association was found between PGD conceived pregnancies and risks of adverse neonatal or obstetrical outcomes compared with ICSI pregnancies. Hence, blastomere biopsy for PGD does not seem to increase the risk for adverse perinatal outcome compared with ICSI pregnancies.
引用
- Hasson J, Limoni D, Malcov M, et al. Obstetric and neonatal outcomes of pregnancies conceived after preimplantation genetic diagnosis: cohort study and meta-analysis. Reprod Biomed Online. 2017. PMID: 28576301. doi:10.1016/j.rbmo.2017.05.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。